Meanwhile, increased TGF-β2 expression at both the mRNA and protein levels was found to be related to poor prognosis in women with TP53-mutated ovarian cancer as well as in cancer patients receiving chemotherapy with platins, Taxol, or a platin+Taxol. This evidence concerns the gene TGFB2 and cancer.